期刊的影响因子--文章列表

期刊文章列表
Xiyue Shen^1,2，Kai Luo¹，Juntao Yuan¹，Junling Gao¹，Bingqing Cui¹，Zhuoran Yu¹，Zhongbing Lu¹（College of Life Science，University of Chinese Academy of Sciences；Institute of Respiratory Medicine，Tongji University School of Medicine）.Hepatic DDAH1 mitigates hepatic steatosis and insulin resistance in obese mice：Involvement of reduced S100A11 expression[J].Acta Pharmaceutica Sinica B,2023,第8期 Qing Pei¹，Bowen Jiang^1,2，Dengyuan Hao^1,2，Zhigang Xie^1,2（State Key Laboratory of Polymer Physics and Chemistry，Changchun Institute of Applied Chemistry，Chinese Academy of Sciences；School of Applied Chemistry and Engineering，University of Science and Technology of China）.Self-assembled nanoformulations of paclitaxel for enhanced cancer theranostics[J].Acta Pharmaceutica Sinica B,2023,第8期 Songya Zhang¹，Lin Zhang²，Anja Greule³，Julien Tailhades^3,4,5，Edward Marschall^3,4,5，Panward Prasongpholchai⁶，Daniel J.Leng⁶，Jingfan Zhang⁷，Jing Zhu¹，Joe A.Kaczmarski⁸，Ralf B.Schittenhelm^3,9，Oliver Einsle²，Colin J.Jackson^5,8，Fabrizio Alberti^6,7，Andreas Bechthold¹⁰，Youming Zhang¹，Manuela Tosin⁶，Tong Si¹，Max J.Cryle^3,4,5（CAS Key Laboratory of Quantitative Engineering Biology，Shenzhen Institute of Synthetic Biology，Shenzhen Institute of Advanced Technology，Chinese Academy of Sciences；Institut für Biochemie，Albert-Ludwigs-Universit?t Freiburg；Department of Biochemistry and Molecular Biology，the Monash Biomedicine Discovery Institute，Monash University；EMBL Australia，Monash University；ARC Centre of Excellence for Innovations in Peptide and Protein Science；Department of Chemistry，University of Warwick；School of Life Sciences，University of Warwick，Gibbet Hill Campus；Research School of Chemistry，the Australian National University；Monash Proteomics and Metabolomics Facility，Monash University；Institute of Pharmaceutical Sciences，Albert-Ludwigs-Universit?t Freiburg）.P450-mediated dehydrotyrosine formation during WS9326 biosynthesis proceeds via dehydrogenation of a specific acylated dipeptide substrate[J].Acta Pharmaceutica Sinica B,2023,第8期 Kailong Ji¹，Wei Liu¹，Weihang Yin¹，Xiangrong Kong²，Honghong Xu¹，Zeng-Wei Lai¹，Jing-Ya Li^1,2，Jian-Min Yue¹（State Key Laboratory of Drug Research，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；School of Chinese Materia Medica，Nanjing University of Chinese Medicine）.A new class of potent liver injury protective compounds：Structural elucidation, total synthesis and bioactivity study[J].Acta Pharmaceutica Sinica B,2023,第8期 Yunting Zhang，Min Jiang，Guangsheng Du，Xiaofang Zhong，Chunting He，Ming Qin，Yingying Hou，Rong Liu，Xun Sun（Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province，Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology，West China School of Pharmacy，Sichuan University）.An antigen self-assembled and dendritic cell-targeted nanovaccine for enhanced immunity against cancer[J].Acta Pharmaceutica Sinica B,2023,第8期 Xiaoqing Fan，Chutian Mai，Ling Zuo，Jumin Huang，Chun Xie，Zebo Jiang，Runze Li，Xiaojun Yao，Xingxing Fan，Qibiao Wu，Peiyu Yan，Liang Liu，Jianxin Chen，Ying Xie，Elaine Lai-Han Leung（Dr Neher's Biophysics Laboratory for Innovative Drug Discovery，State Key Laboratory of Quality Research in Chinese Medicine，Macao University of Science and Technology，Taipa，Macao 999078；Beijing University of Chinese Medicine，Beijing 100029）.Author correction to "Herbal formula Ba Wei Bai Du San alleviates polymicrobial sepsisinduced liver injury via increasing the gut microbiota Lactobacillus johnsonii and regulating macrophage anti-inflammatory activity in mice"[J].药学学报(英文版),2023,第8期 Linglong Deng，Hannah Petrek，Mei-Juan Tu，Neelu Batra，Ai-Xi Yu，Ai-Ming Yu（Department of Orthopaedic Trauma and Microsurgery，Zhongnan Hospital of Wuhan University，Wuhan 430072；Department of Biochemistry and Molecular Medicine，UC Davis School of Medicine，Sacramento，CA 95817，USA）.Author correction to "Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis in vivo"[J].药学学报(英文版),2023,第8期 Ziru Yu，Dewen Kong，Yu Liang，Xiaoyue Zhao，Guanhua Du（State Key Laboratory of Bioactive Substances and Functions of Natural Medicines，Beijing Key Laboratory of Drug Target and Screening Research，Institute of Materia Medica，Chinese Academy of Medical Sciences and Peking Union Medical College，Beijing 100050）.Author correction to "Protective effects of VMY-2-95 on corticosterone-induced injuries in mice and cellular models"[J].药学学报(英文版),2023,第8期 Guangdi Li，Yali Wang，Erik De Clercq（Hunan Provincial Key Laboratory of Clinical Epidemiology，Xiangya School of Public Health，Central South University，Changsha 410078；Rega Institute for Medical Research，Department of Microbiology and Immunology，KU Leuven，Leuven B-3000，Belgium）.Author correction to "Approved HIV reverse transcriptase inhibitors in the past decade"[J].药学学报(英文版),2023,第8期 Dayong Zheng¹，Jun Li²，Han Yan¹，Gang Zhang³，Wei Li¹，Edward Chu⁴，Ning Wei⁴（School of Pharmacy，North China University of Science and Technology；Basic Medical Science College，Liaoning University of Traditional Chinese Medicine；Division of Biology and Biological Engineering，California Institute of Technology；Department of Oncology and Cancer Therapeutics Program，Montefiore Einstein Cancer Center，Albert Einstein College of Medicine）.Emerging roles of Aurora-A kinase in cancer therapy resistance[J].Acta Pharmaceutica Sinica B,2023,第7期 Meng Pan¹，Danrong Hu^1,2，Liping Yuan¹，Yan Yu¹，Yicong Li¹，Zhiyong Qian¹（State Key Laboratory of Biotherapy and Cancer Center，West China Hospital，Sichuan University，Collaborative Innovation Center of Biotherapy；Rehabilitation Medicine Center and Institute of Rehabilitation Medicine，Key Laboratory of Rehabilitation Medicine in Sichuan Province，West China Hospital，Sichuan University）.Newly developed gas-assisted sonodynamic therapy in cancer treatment[J].Acta Pharmaceutica Sinica B,2023,第7期 Zhun Lin¹，Zhengyu Zou²，Zhe Pu¹，Minhao Wu²，Yuanqing Zhang¹（School of Pharmaceutical Sciences，Sun Yat-sen University；Zhongshan School of Medicine，Sun Yat-sen University）.Application of microfluidic technologies on COVID-19 diagnosis and drug discovery[J].Acta Pharmaceutica Sinica B,2023,第7期 Junwoo Lee¹，Dongwoo Khang^1,2,3,4（College of Medicine，Gachon University；Lee Gil Ya Cancer and Diabetes Institute，Gachon University；Gachon Advanced Institute for Health Science & Technology，Gachon University；Department of Physiology，College of Medicine，Gachon University）.Mucosal delivery of nanovaccine strategy against COVID-19 and its variants[J].Acta Pharmaceutica Sinica B,2023,第7期 Lin Zhang¹，Dongna Li¹，Pengrong Yi¹，Jiangwei Shi^2,3，Mengqing Guo¹，Qingsheng Yin^1,4，Dingbin Liu⁵，Pengwei Zhuang^1,4，Yanjun Zhang^1,4,2,3（State Key Laboratory of Component-based Chinese Medicine，Tianjin University of Traditional Chinese Medicine；First Teaching Hospital of Tianjin University of Traditional Chinese Medicine；National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion；Haihe Laboratory of Modern Chinese Medicine；State Key Laboratory of Medicinal Chemical Biology，Research Center for Analytical Sciences，and Tianjin Key Laboratory of Molecular Recognition and Biosensing，College of Chemistry，Nankai University）.Peripheral origin exosomal micro RNAs aggravate glymphatic system dysfunction in diabetic cognitive impairment[J].Acta Pharmaceutica Sinica B,2023,第7期 Luchen Sun¹，Nanfei Yang²，Bing Chen³，Yuncheng Bei⁴，Zisheng Kang⁵，Can Zhang⁵，Nan Zhang⁶，Peipei Xu³，Wei Yang⁷，Jia Wei⁴，Jiangqiong Ke¹，Weijian Sun¹，Xiaokun Li⁸，Pingping Shen^1,9,10（The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University；School of Pharmaceutical Science，Wenzhou Medical University；Department of Hematology，the Affiliated Drum Tower Hospital of Nanjing University Medical School；The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital，the Affiliated Hospital of Nanjing University Medical School，Nanjing University；State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases，Center of Drug Discovery，China Pharmaceutical University；Centre of Micro/Nano Manufacturing Technology (MNMT-Dublin)，School of Mechanical & Materials Engineering，University College Dublin；Department of Surgery，Division of Cancer Biology and Therapeutics，Cedars-Sinai Medical Center；Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine，Vision and Brain Health) & School of Pharmaceutical Science，Wenzhou Medical University；Department of Urology，Drum Tower Hospital，Medical School of Nanjing University，Institute of Urology，Nanjing University；Shenzhen Research Institute of Nanjing University）.A novel mesenchymal stem cell-based regimen for acute myeloid leukemia differentiation therapy[J].Acta Pharmaceutica Sinica B,2023,第7期 Jingnan Zhang，Ze Zhang，Zhenlin Huang，Manlin Li，Fan Yang，Zeqi Wu，Qian Guo，Xiyu Mei，Bin Lu，Changhong Wang，Zhengtao Wang，Lili Ji（The MOE Key Laboratory for Standardization of Chinese Medicines，Shanghai Key Laboratory of Compound Chinese Medicines and the SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines，Institute of Chinese Materia Medica，Shanghai University of Traditional Chinese Medicine）.Isotoosendanin exerts inhibition on triple-negative breast cancer through abrogating TGF-β-induced epithelial—mesenchymal transition via directly targeting TGFβR1[J].Acta Pharmaceutica Sinica B,2023,第7期 Jingwen Dong，Chenfei Zhu，Ying Huang，Quanhao Li，Jing Li，Zheng Wang，Yixin Wang，Zhanwei Zhou，Minjie Sun（NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients，State Key Laboratory of Natural Medicines，Department of Pharmaceutics，China Pharmaceutical University）.Reversing the PAI-1-induced fibrotic immune exclusion of solid tumor by multivalent CXCR4 antagonistic nano-permeator[J].Acta Pharmaceutica Sinica B,2023,第7期 Letian Li¹，Jiayi Hao¹，Yuhang Jiang¹，Pengfei Hao¹，Yuwei Gao¹，Jing Chen¹，Guoqing Zhang¹，Ningyi Jin¹，Maopeng Wang²，Chang Li¹（Research Unit of Key Technologies for Prevention and Control of Virus Zoonoses，Chinese Academy of Medical Sciences，Changchun Veterinary Research Institute，Chinese Academy of Agricultural Sciences；Wenzhou Key Laboratory for Virology and Immunology，Institute of Virology，Wenzhou University）.A micro-sized vaccine based on recombinant Lactiplantibacillus plantarum fights against SARS-CoV-2 infection via intranasal immunization[J].Acta Pharmaceutica Sinica B,2023,第7期 Yi-Zheng Fang^1,2,3，Li Jiang^1,2,3，Qiaojun He^2,3,4，Ji Cao^1,2,3，Bo Yang^1,2（Institute of Pharmacology and Toxicology，Zhejiang Province Key Laboratory of Anti-Cancer Drug Research，College of Pharmaceutical Sciences，Zhejiang University；The Innovation Institute for Artificial Intelligence in Medicine，Zhejiang University；Cancer Center of Zhejiang University；Center for Drug Safety Evaluation and Research of Zhejiang University）.Deubiquitination complex platform：A plausible mechanism for regulating the substrate specificity of deubiquitinating enzymes[J].Acta Pharmaceutica Sinica B,2023,第7期 Lin Hou^1,2,3，Xueyuan Peng^1,2，Ruiting Wang^1,2，Yifei Wang^1,2，Hong Li^1,2，Huijuan Zhang^1,2,3，Yun Zhang^1,2,3，Zhenzhong Zhang^1,2,3（School of Pharmaceutical Sciences，Zhengzhou University；Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases，Zhengzhou University；Collaborative Innovation Center of New Drug Research and Safety Evaluation，Zhengzhou University）.Oral nano-formulation improves pancreatic islets dysfunction via lymphatic transport for antidiabetic treatment[J].Acta Pharmaceutica Sinica B,2023,第7期 Yiqun Li，Mingrui Yang，Yanan Nan，Jiaming Wang，Sanjiao Wang，Dongxiao Cui，Jiajian Guo，Pengfei He，Wenxin Dai，Shuqi Zhou，Yue Zhang，Wenfu Ma（School of Life Science，Beijing University of Chinese Medicine）.SARS-CoV-2 spike host cell surface exposure promoted by a COPI sorting inhibitor[J].Acta Pharmaceutica Sinica B,2023,第7期 Ya-Li Sang^1,2,3，Christophe Pannecouque⁴，Erik De Clercq⁴，Shuai Wang^1,2，Fen-Er Chen^1,2,3（Department of Chemistry，Engineering Center of Catalysis and Synthesis for Chiral Molecules，Fudan University；Shanghai Engineering Center of Industrial Asymmetric Catalysis for Chiral Drugs；School of Science，Harbin Institute of Technology (Shenzhen)；Rega Institute for Medical Research，KU Leuven）.Picomolar inhibitor of reverse transcriptase featuring significantly improved metabolic stability[J].Acta Pharmaceutica Sinica B,2023,第7期 Zhiwen Li，Zhihao Guo，Xi Lu，Xican Ma，Xiukun Wang，Rui Zhang，Xinxin Hu，Yanxiang Wang，Jing Pang，Tianyun Fan，Yonghua Liu，Sheng Tang，Haigen Fu，Jingpu Zhang，Yinghong Li，Xuefu You，Danqing Song（Beijing Key Laboratory of Antimicrobial Agents，Institute of Medicinal Biotechnology，Chinese Academy of Medical Sciences and Peking Union Medical College）.Evolution and development of potent monobactam sulfonate candidate IMBZ18g as a dual inhibitor against MDR Gram-negative bacteria producing ESBLs[J].Acta Pharmaceutica Sinica B,2023,第7期 Liang He¹，Ziwei Xu²，Xin Niu²，Rong Li¹，Fanhua Wang¹，Yu You²，Jingduo Gao²，Lei Zhao¹，Karan M.Shah³，Jian Fan⁴，Mingyao Liu²，Jian Luo¹（Yangzhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center)，Tongji University School of Medicine；Shanghai Key Laboratory of Regulatory Biology，Institute of Biomedical Sciences and School of Life Sciences，East China Normal University；Department of Oncology and Metabolism，the Medical School，the University of Sheffield；Department of Orthopedics，Tongji Hospital，Tongji University School of Medicine）.GPRC5B protects osteoarthritis by regulation of autophagy signaling[J].Acta Pharmaceutica Sinica B,2023,第7期 Zhuang Li¹，Na Liu²，Wanzhen Yang²，Jie Tu²，Yahui Huang²，Wei Wang^1,3，Chunquan Sheng²（State Key Laboratory of Bioengineering Reactor，And Shanghai Key Laboratory of New Drug Design，School of Pharmacy，East China University of Science & Technology；School of Pharmacy，Second Military Medical University (Naval Medical University)；Department of Pharmacology and Toxicology，College of Pharmacy，And BIO5 Institute，University of Arizona）.Controlling antifungal activity with light：Optical regulation of fungal ergosterol biosynthetic pathway with photo-responsive CYP51 inhibitors[J].Acta Pharmaceutica Sinica B,2023,第7期 Qiaobo Xie¹，Yanyan Chu²，Wenmin Yuan³，Yanan Li⁴，Keqin Li¹，Xinfeng Wu¹，Xiaohui Liu¹，Rui Xu¹，Shuxiang Cui⁴，Xianjun Qu¹（Department of Pharmacology，School of Basic Medical Sciences，Capital Medical University；Ocean University of China，School of Medicine and Pharmacy；Marine Biomedical Research Institute of Qingdao；Department of Toxicology and Sanitary Chemistry，Beijing Key Laboratory of Environmental Toxicology，School of Public Health，Capital Medical University）.Activation of insulin-like growth factor-1 receptor （IGF-1R） promotes growth of colorectal cancer through triggering the MEX3A-mediated degradation of RIG-Ⅰ[J].Acta Pharmaceutica Sinica B,2023,第7期 Shuai Xiong¹，Hui Xiao¹，Meng Sun¹，Yunjie Liu¹，Ling Gao¹，Ke Xu¹，Haiying Liang¹，Nan Jiang²，Yuhui Lin¹，Lei Chang¹，Haiyin Wu^1,3，Dongya Zhu^1,3，Chunxia Luo^1,3（Department of Pharmacology，School of Pharmacy，Nanjing Medical University；Department of Medicinal Chemistry，School of Pharmacy，Nanjing Medical University；Collaborative Innovation Center for Cardiovascular Disease Translational Medicine，Nanjing Medical University）.Glutamate-releasing BEST1 channel is a new target for neuroprotection against ischemic stroke with wide time window[J].Acta Pharmaceutica Sinica B,2023,第7期 Mojtaba Shamsipur，Atefeh Ghavidast，Afshin Pashabadi（Department of Chemistry，Razi University）.Phototriggered structures：Latest advances in biomedical applications[J].Acta Pharmaceutica Sinica B,2023,第7期 Aihua Wu，Afeng Yang，Qinli Tong，Guoguang Wei，Sihang Zhang，Sheng Yu，Chen Zhang，Jiaojiao Xu，Wei Lu（School of Pharmacy ＆ Minhang Hospital，Key Laboratory of Smart Drug Delivery，Ministry of Education，＆ State Key Laboratory of Molecular Engineering of Polymers，Fudan University）.A rationally designed cancer vaccine based on NIR-II fluorescence image-guided light-triggered remote control of antigen cross-presentation and autophagy[J].Acta Pharmaceutica Sinica B,2023,第7期首页上一页 3 4 5 6 7 下一页尾页共有12页，转到页

期刊文章列表